OFIX ORTHOFIX MED INC revenue, earnings and financials

For the quarter ended June 30, 2026, ORTHOFIX MED INC reported revenue of $211M (up 3.8% from a year earlier), net income of −$15.8M and diluted EPS of −$0.39; over the last four quarters revenue was $833M and net income −$61.7M; for the fiscal year ended December 2025 revenue was $822M, up 2.9% on the year before.

OFIX annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $822M, gross profit $566M, operating income −$81.4M, net income −$92.2M (margin -11.2%), EPS −$2.33
• Fiscal year ended Dec 2024: revenue $799M, gross profit $546M, operating income −$84.6M, net income −$126M (margin -15.8%), EPS −$3.30
• Fiscal year ended Dec 2023: revenue $747M, gross profit $486M, operating income −$139M, net income −$151M (margin -20.3%), EPS −$4.12
• Fiscal year ended Dec 2022: revenue $461M, gross profit $337M, operating income −$13.3M, net income −$19.8M (margin -4.3%), EPS −$0.98
• Fiscal year ended Dec 2021: revenue $464M, gross profit $350M, operating income −$8.32M, net income −$38.4M (margin -8.3%), EPS −$1.95

OFIX quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $211M (up 3.8% year over year), net income −$15.8M, EPS −$0.39
• Quarter ended Mar 31, 2026: revenue $197M (up 1.6% year over year), net income −$20.9M, EPS −$0.52
• Quarter ended Dec 31, 2025 (from the annual report): revenue $220M (up 2.0% year over year), net income −$2.22M, EPS −$0.05
• Quarter ended Sep 30, 2025: revenue $206M (up 4.6% year over year), net income −$22.8M, EPS −$0.57
• Quarter ended Jun 30, 2025: revenue $203M (up 2.3% year over year), net income −$14.1M, EPS −$0.36
• Quarter ended Mar 31, 2025: revenue $194M (up 2.7% year over year), net income −$53.1M, EPS −$1.35
• Quarter ended Dec 31, 2024 (from the annual report): revenue $216M (up 7.6% year over year), net income −$29.1M, EPS −$0.76
• Quarter ended Sep 30, 2024: revenue $197M (up 6.8% year over year), net income −$27.4M, EPS −$0.71
• Quarter ended Jun 30, 2024: revenue $199M (up 6.2% year over year), net income −$33.4M, EPS −$0.88
• Quarter ended Mar 31, 2024: revenue $189M (up 7.7% year over year), net income −$36.0M, EPS −$0.95
• Quarter ended Dec 31, 2023 (from the annual report): revenue $200M (up 64.0% year over year), net income −$22.2M, EPS −$0.57
• Quarter ended Sep 30, 2023: revenue $184M (up 61.4% year over year), net income −$28.9M, EPS −$0.77
• Quarter ended Jun 30, 2023: revenue $187M (up 58.4% year over year), net income −$39.4M, EPS −$1.07
• Quarter ended Mar 31, 2023: revenue $175M (up 64.6% year over year), net income −$60.9M, EPS −$1.71
• Quarter ended Dec 31, 2022 (from the annual report): revenue $122M (down 2.3% year over year), net income −$7.06M, EPS −$0.35
• Quarter ended Sep 30, 2022: revenue $114M (up 1.4% year over year), net income −$10.7M, EPS −$0.53
• Quarter ended Jun 30, 2022: revenue $118M (down 2.7% year over year), net income $2.49M, EPS $0.12
• Quarter ended Mar 31, 2022: revenue $106M (up 0.8% year over year), net income −$4.46M, EPS −$0.22
• Quarter ended Dec 31, 2021 (from the annual report): revenue $125M, net income −$32.8M, EPS −$1.88
• Quarter ended Sep 30, 2021: revenue $112M, net income −$2.17M, EPS $0.11

OFIX cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $33.3M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $25.8M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$45.8M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$11.5M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $18.5M, share buybacks n/a

OFIX balance sheet

• Jun 30, 2026: cash $104M, total assets $873M, total liabilities $444M, shareholders' equity $429M, long-term debt $222M
• Mar 31, 2026: cash $120M, total assets $887M, total liabilities $451M, shareholders' equity $435M, long-term debt $221M
• Dec 31, 2025: cash $82.0M, total assets $851M, total liabilities $401M, shareholders' equity $450M, long-term debt $157M
• Sep 30, 2025: cash $62.9M, total assets $833M, total liabilities $390M, shareholders' equity $442M, long-term debt $157M
• Jun 30, 2025: cash $65.6M, total assets $837M, total liabilities $379M, shareholders' equity $458M, long-term debt $157M
• Mar 31, 2025: cash $58.0M, total assets $823M, total liabilities $365M, shareholders' equity $458M, long-term debt $157M
• Dec 31, 2024: cash $83.2M, total assets $893M, total liabilities $390M, shareholders' equity $503M, long-term debt $157M
• Sep 30, 2024: cash $30.1M, total assets $868M, total liabilities $342M, shareholders' equity $526M, long-term debt $112M

What is OFIX's revenue?

ORTHOFIX MED INC reported $833M of revenue over its last four quarters, through June 30, 2026.

Is OFIX profitable?

No. ORTHOFIX MED INC lost $61.7M over the last four quarters.

What is OFIX's EPS?

Diluted earnings per share over the last four quarters were −$1.53; −$0.39 in the latest quarter.

OFIX ownership and insider trades · All stocks